# Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases

> **NCT04413292** · — · COMPLETED · sponsor: **South Valley University** · enrollment: 93 (actual)

## Conditions studied

- Bronchial Neoplasm Benign

## Interventions

- **DIAGNOSTIC_TEST:** ELISA assays and Westren blot analysis of survivin and fibulin-3 expression

## Key facts

- **NCT ID:** NCT04413292
- **Lead sponsor:** South Valley University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2019-12-30
- **Final completion:** 2020-04-01
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04413292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04413292, "Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04413292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*